Boceprevir based triple therapy in combination with peginterferon-alfa-2a plus ribavirin (P/R) under real life conditions in treatment naïve patients infected with chronic hepatitis c, genotype 1: An interim analysis at week 12 after start of treatment

Authors
Category Primary study
JournalGastroenterology
Year 2013
This article has no abstract
Epistemonikos ID: fab32b420f4be910a9e2f08dfd022fb9cb27c699
First added on: Feb 05, 2025